88872680
Apr 15, 2020
ALNYLAM PHARMACEUTICALS INC.
Subscribe
Maintaining a clinical registry database for patients with mutations of the transthyretin gene; maintaining a registry on the clinical outcomes of ATTR amyloidosis in patients over time